Mihaela Simu este profesor la UMF „Victor Babeș” Timișoara și conduce Secția neurologie II din Spitalul Clinic Județean de Urgență „Pius Brînzeu” Timișoara
Elena Cecilia Roșca este medic primar neurologie la Spitalul Clinic Județean de Urgență „Pius Brînzeu” Timișoara și șef de lucrări la UMF „Victor Babeș” Timișoara
Patogeneză
Manifestări clinice
Tratament
Bibliografie
1. Auche M. Des alterations des nerfs périphériques. Arch med Exp anat Pathol. 1890;2:635
2. Leyden E. Entzundung der peripheren Nerven. Deut Militar Zeitsch. 1887;17:49
3. Pryce TD. On diabetic neuritis with clinical and pathological description of three cases of diabetic pseudo-tabes. Brain. 1893;16:416
4. Kraus WM. Involvement of peripheral neurons in diabetes mellitus. Arch Neurol Psychiatry. 1922;7:202
5. Tesfaye S et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93
6. Pfeifer MA et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984 Sep-Oct;7(5):447-53
7. Dyck PJ et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817-24
8. Ziegler D et al. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications. 1992 Jan-Mar;6(1):49-57
9. Vinik AI et al. Diabetic autonomic neuropathy. Diabetes Care. 2003 May;26(5):1553-79
10. Verrotti A et al. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne). 2014 Dec 1;5:205
11. Greene DA et al. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes. 1988 Jun;37(6):688-93
12. Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 1997 Sep;46 Suppl 2:S31-7
13. Hoeldtke RD et al. Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes. Diabetes. 2002 Sep;51(9):2817-25
14. Ejskjaer NT et al. Autoimmunity in diabetic autonomic neuropathy: does the immune system get on your nerves? Diabet Med. 1998 Sep;15(9):723-9
15. Apfel SC et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994 Jan 14;634(1):7-12
16. Horrobin DF. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes. 1997 Sep;46 Suppl 2:S90-3
17. Dyck PJ et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999 Sep;22(9):1479-86
18. Tesfaye S et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996 Nov;39(11):1377-84
19. Forrest KY et al. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes. 1997 Apr;46(4):665-70
20. Ziegler D et al. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab. 1993;19(1 Pt 2):143-51
21. Kahn JK et al. Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care. 1986 Jul-Aug;9(4):389-94
22. Ewing DJ et al. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991 Mar;34(3):182-5
23. Karayannis G et al. Diabetic cardiovascular autonomic neuropathy: Clinical implications. Expert review of cardiovascular therapy. 2012;10:747-765
24. Valensi P et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001 Feb;24(2):339-43
25. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol. 1997
Jan 15;79(2):134-9
26. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65
27. Ewing DJ et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985 Sep-Oct;8(5):491-8
28. England JD et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009 Jan 13;72(2):177-84
29. Maleki D et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000 Oct 9;160(18):2808-16
30. Golbidi S, Laher I. Bladder dysfunction in diabetes mellitus. Front Pharmacol. 2010 Nov 16;1:136
31. Toda N et al. Nitric oxide and penile erectile function. Pharmacol Ther. 2005 May;106(2):233-66
32. Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep. 2002 Dec;2(6):501-9
33. Wigington G et al. Skin blood flow in diabetic dermopathy. Arch Dermatol.
2004 Oct;140(10):1248-50
34. Shaw JE et al. Gustatory sweating in diabetes mellitus. Diabet Med. 1996 Dec;13(12):1033-7
35. Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1115-21
36. Pittasch D et al. Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care. 2002 Sep;25(9):1545-50
37. Alio J et al. Pupil responsiveness in diabetes mellitus. Ann Ophthalmol. 1989 Apr;21(4):132-7
38. Vallianou N et al. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud. 2009 Winter;6(4):230-6
39. Oldenburg O et al. Treatment of orthostatic hypotension. Curr Opin Pharmacol. 2002 Dec;2(6):740-7
40. Dhir R, Richter JE. Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol. 2004 Mar;38(3):237-42
41. Basu A, Ryder RE. New treatment options for erectile dysfunction in patients with diabetes mellitus. Drugs. 2004;64(23):2667-88
42. Penson DF, Wessells H. Erectile dysfunction in diabetic patients. Diabetes Spectrum 2004;17 (4): 225-230
43. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007 Jan 23;115(3):387-97
44. Vinik AI et al. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013 Dec;42(4):747-87
Dacă vrei să fii la curent cu tot ce se întâmplă în lumea medicală, abonează-te la „Viața Medicală”, publicația profesională, socială și culturală a profesioniștilor în Sănătate din România!
Titularii abonamentelor pe 12 luni sunt creditați astfel de:
Cookie-urile ne ajută să vă îmbunătățim experiența pe site-ul nostru. Prin continuarea navigării pe site-ul www.viata-medicala.ro, veți accepta implicit folosirea de cookie-uri pe parcursul vizitei dumneavoastră.
Da, sunt de acord Aflați mai multe